• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

疫苗接种前后英格兰 COVID-19 住院结局趋势:一项队列研究。

Trends in COVID-19 hospital outcomes in England before and after vaccine introduction, a cohort study.

机构信息

Medical Research Council Biostatistics Unit, School of Clinical Medicine, University of Cambridge, Cambridge, UK.

UK Health Security Agency, London, UK.

出版信息

Nat Commun. 2022 Aug 17;13(1):4834. doi: 10.1038/s41467-022-32458-y.

DOI:10.1038/s41467-022-32458-y
PMID:35977938
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9382625/
Abstract

Widespread vaccination campaigns have changed the landscape for COVID-19, vastly altering symptoms and reducing morbidity and mortality. We estimate trends in mortality by month of admission and vaccination status among those hospitalised with COVID-19 in England between March 2020 to September 2021, controlling for demographic factors and hospital load. Among 259,727 hospitalised COVID-19 cases, 51,948 (20.0%) experienced mortality in hospital. Hospitalised fatality risk ranged from 40.3% (95% confidence interval 39.4-41.3%) in March 2020 to 8.1% (7.2-9.0%) in June 2021. Older individuals and those with multiple co-morbidities were more likely to die or else experienced longer stays prior to discharge. Compared to unvaccinated people, the hazard of hospitalised mortality was 0.71 (0.67-0.77) with a first vaccine dose, and 0.56 (0.52-0.61) with a second vaccine dose. Compared to hospital load at 0-20% of the busiest week, the hazard of hospitalised mortality during periods of peak load (90-100%), was 1.23 (1.12-1.34). The prognosis for people hospitalised with COVID-19 in England has varied substantially throughout the pandemic and according to case-mix, vaccination, and hospital load. Our estimates provide an indication for demands on hospital resources, and the relationship between hospital burden and outcomes.

摘要

广泛的疫苗接种运动改变了 COVID-19 的局面,极大地改变了症状,并降低了发病率和死亡率。我们估计了 2020 年 3 月至 2021 年 9 月期间在英格兰因 COVID-19 住院的患者中按入院月份和疫苗接种状况划分的死亡率趋势,同时控制了人口统计学因素和医院负担。在 259727 例因 COVID-19 住院的患者中,有 51948 例(20.0%)在住院期间死亡。住院病死率从 2020 年 3 月的 40.3%(95%置信区间 39.4-41.3%)降至 2021 年 6 月的 8.1%(7.2-9.0%)。年龄较大的患者和患有多种合并症的患者更有可能死亡,或在出院前经历更长的住院时间。与未接种疫苗的人相比,首次接种疫苗的住院死亡风险为 0.71(0.67-0.77),第二次接种疫苗的风险为 0.56(0.52-0.61)。与医院负荷处于最繁忙周的 0-20%相比,在高峰期(90-100%)的住院死亡风险为 1.23(1.12-1.34)。英格兰 COVID-19 住院患者的预后在整个大流行期间以及根据病例组合、疫苗接种和医院负荷而有了显著变化。我们的估计为医院资源需求提供了一个指标,并说明了医院负担与结局之间的关系。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d897/9385724/d86abe059c1e/41467_2022_32458_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d897/9385724/5ded2c5e4051/41467_2022_32458_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d897/9385724/6ca9a9963960/41467_2022_32458_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d897/9385724/b3d685cd5fcb/41467_2022_32458_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d897/9385724/f8183eb17987/41467_2022_32458_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d897/9385724/b47d4cbd4810/41467_2022_32458_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d897/9385724/d86abe059c1e/41467_2022_32458_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d897/9385724/5ded2c5e4051/41467_2022_32458_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d897/9385724/6ca9a9963960/41467_2022_32458_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d897/9385724/b3d685cd5fcb/41467_2022_32458_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d897/9385724/f8183eb17987/41467_2022_32458_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d897/9385724/b47d4cbd4810/41467_2022_32458_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d897/9385724/d86abe059c1e/41467_2022_32458_Fig6_HTML.jpg

相似文献

1
Trends in COVID-19 hospital outcomes in England before and after vaccine introduction, a cohort study.疫苗接种前后英格兰 COVID-19 住院结局趋势:一项队列研究。
Nat Commun. 2022 Aug 17;13(1):4834. doi: 10.1038/s41467-022-32458-y.
2
Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study.比较分析英国住院和死亡风险与 SARS-CoV-2 奥密克戎(B.1.1.529)和德尔塔(B.1.617.2)变异株的关系:一项队列研究。
Lancet. 2022 Apr 2;399(10332):1303-1312. doi: 10.1016/S0140-6736(22)00462-7. Epub 2022 Mar 16.
3
Waning effectiveness of BNT162b2 and ChAdOx1 covid-19 vaccines over six months since second dose: OpenSAFELY cohort study using linked electronic health records.第二剂接种后 6 个月以上 BNT162b2 和 ChAdOx1 新冠疫苗效力下降:使用电子健康记录链接的 OpenSAFELY 队列研究。
BMJ. 2022 Jul 20;378:e071249. doi: 10.1136/bmj-2022-071249.
4
Associations of BMI with COVID-19 vaccine uptake, vaccine effectiveness, and risk of severe COVID-19 outcomes after vaccination in England: a population-based cohort study.英国基于人群的队列研究:BMI 与 COVID-19 疫苗接种率、疫苗有效性以及接种后 COVID-19 严重结局风险的关联。
Lancet Diabetes Endocrinol. 2022 Aug;10(8):571-580. doi: 10.1016/S2213-8587(22)00158-9. Epub 2022 Jul 1.
5
Association of COVID-19 Vaccinations With Intensive Care Unit Admissions and Outcome of Critically Ill Patients With COVID-19 Pneumonia in Lombardy, Italy.意大利伦巴第地区 COVID-19 疫苗接种与入住重症监护病房以及 COVID-19 肺炎重症患者结局的相关性。
JAMA Netw Open. 2022 Oct 3;5(10):e2238871. doi: 10.1001/jamanetworkopen.2022.38871.
6
COVID-19 hospital admissions and deaths after BNT162b2 and ChAdOx1 nCoV-19 vaccinations in 2·57 million people in Scotland (EAVE II): a prospective cohort study.苏格兰 257 万人中 BNT162b2 和 ChAdOx1 nCoV-19 疫苗接种后 COVID-19 住院和死亡情况(EAVE II):一项前瞻性队列研究。
Lancet Respir Med. 2021 Dec;9(12):1439-1449. doi: 10.1016/S2213-2600(21)00380-5. Epub 2021 Sep 29.
7
Incidence of diabetes after SARS-CoV-2 infection in England and the implications of COVID-19 vaccination: a retrospective cohort study of 16 million people.英格兰地区 2019 冠状病毒病(COVID-19)大流行期间感染 SARS-CoV-2 后发生糖尿病的发病率:一项涉及 1600 万人的回顾性队列研究。
Lancet Diabetes Endocrinol. 2024 Aug;12(8):558-568. doi: 10.1016/S2213-8587(24)00159-1.
8
Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study.辉瑞-生物科技疫苗和牛津-阿斯利康疫苗对英格兰老年人新冠病毒相关症状、住院及死亡率的有效性:检测阴性病例对照研究
BMJ. 2021 May 13;373:n1088. doi: 10.1136/bmj.n1088.
9
Risk of myocarditis and pericarditis after a COVID-19 mRNA vaccine booster and after COVID-19 in those with and without prior SARS-CoV-2 infection: A self-controlled case series analysis in England.在有和没有先前 SARS-CoV-2 感染的人群中,COVID-19 mRNA 疫苗加强针接种后和 COVID-19 后心肌炎和心包炎的风险:在英国的一项自身对照病例系列分析。
PLoS Med. 2023 Jun 7;20(6):e1004245. doi: 10.1371/journal.pmed.1004245. eCollection 2023 Jun.
10
Vaccine effectiveness of the first dose of ChAdOx1 nCoV-19 and BNT162b2 against SARS-CoV-2 infection in residents of long-term care facilities in England (VIVALDI): a prospective cohort study.英格兰长期护理机构居民中 ChAdOx1 nCoV-19 与 BNT162b2 疫苗首针接种对 SARS-CoV-2 感染的疫苗有效性(VIVALDI):一项前瞻性队列研究。
Lancet Infect Dis. 2021 Nov;21(11):1529-1538. doi: 10.1016/S1473-3099(21)00289-9. Epub 2021 Jun 23.

引用本文的文献

1
A national population-based study of mortality and risk factors in COVID-19-hospitalized patients in Spain (2020-2021).一项基于全国人口的西班牙新冠住院患者死亡率及风险因素研究(2020 - 2021年)
Front Public Health. 2025 Feb 4;13:1488283. doi: 10.3389/fpubh.2025.1488283. eCollection 2025.
2
The Impact of Vaccination on COVID-19 Outcomes in Vietnam.疫苗接种对越南新冠疫情结局的影响
Diagnostics (Basel). 2024 Dec 18;14(24):2850. doi: 10.3390/diagnostics14242850.
3
The Association between COVID-19 Status and Economic Costs in the Early Stages of the COVID-19 Pandemic: Evidence from a UK Symptom Surveillance Digital Survey.

本文引用的文献

1
Adjusting for time of infection or positive test when estimating the risk of a post-infection outcome in an epidemic.在估计传染病后结果的风险时,调整感染时间或阳性检测结果。
Stat Methods Med Res. 2022 Oct;31(10):1942-1958. doi: 10.1177/09622802221107105. Epub 2022 Jun 12.
2
Survival among people hospitalized with COVID-19 in Switzerland: a nationwide population-based analysis.在瑞士因 COVID-19 住院的人群中的存活率:一项全国范围内基于人群的分析。
BMC Med. 2022 Apr 26;20(1):164. doi: 10.1186/s12916-022-02364-7.
3
Association between multimorbidity and mortality in a cohort of patients admitted to hospital with COVID-19 in Scotland.
新冠疫情早期阶段新冠病毒感染状况与经济成本之间的关联:来自英国症状监测数字调查的证据
Pharmacoecon Open. 2025 Mar;9(2):231-245. doi: 10.1007/s41669-024-00544-0. Epub 2024 Nov 28.
4
The Impact of Healthcare Pressures on the COVID-19 Hospitalisation Fatality Risk in England.医疗压力对英格兰新冠肺炎住院死亡风险的影响
J Epidemiol Glob Health. 2024 Dec;14(4):1579-1590. doi: 10.1007/s44197-024-00310-9. Epub 2024 Oct 8.
5
The effectiveness of COVID-19 vaccination in preventing hospitalisation and mortality: A nationwide cross-sectional study in Iran.COVID-19 疫苗接种在预防住院和死亡方面的有效性:伊朗全国性的横断面研究。
J Glob Health. 2024 Sep 27;14:05026. doi: 10.7189/jogh.14.05026.
6
Antiviral effect of Evusheld in COVID-19 hospitalized patients infected with pre-Omicron or Omicron variants: a modelling analysis of the randomized DisCoVeRy trial.Evusheld 对感染前奥密克戎或奥密克戎变异株的 COVID-19 住院患者的抗病毒效果:一项随机 DisCoVeRy 试验的建模分析。
J Antimicrob Chemother. 2024 Nov 4;79(11):2887-2895. doi: 10.1093/jac/dkae301.
7
Telemedical management of symptomatic COVID-19 outpatients.有症状的新冠门诊患者的远程医疗管理
ERJ Open Res. 2024 Aug 12;10(4). doi: 10.1183/23120541.00277-2024. eCollection 2024 Jul.
8
Effects of antivirals on patients with COVID-19 breakthrough.抗病毒药物对 COVID-19 突破性感染患者的影响。
BMC Infect Dis. 2024 Jan 2;24(1):25. doi: 10.1186/s12879-023-08952-z.
9
Nosocomial SARS-CoV-2 Infections and Mortality During Unique COVID-19 Epidemic Waves.医院获得性 SARS-CoV-2 感染与新冠疫情期间独特流行波次中的死亡率。
JAMA Netw Open. 2023 Nov 1;6(11):e2341936. doi: 10.1001/jamanetworkopen.2023.41936.
10
Investigation of Initial Viral Loads and Patient Characteristics as Predictors of COVID-19 Outcomes: A Retrospective Cohort Study.新冠病毒疾病(COVID-19)结局预测指标之初始病毒载量与患者特征的调查:一项回顾性队列研究
Infect Dis Rep. 2023 Oct 8;15(5):589-599. doi: 10.3390/idr15050057.
苏格兰因 COVID-19 住院患者队列中合并症与死亡率之间的关联。
J R Soc Med. 2022 Jan;115(1):22-30. doi: 10.1177/01410768211051715. Epub 2021 Oct 21.
4
Healthcare-associated COVID-19 in England: A national data linkage study.英格兰与医疗保健相关的 COVID-19:一项全国性的数据关联研究。
J Infect. 2021 Nov;83(5):565-572. doi: 10.1016/j.jinf.2021.08.039. Epub 2021 Aug 30.
5
Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study.辉瑞-生物科技疫苗和牛津-阿斯利康疫苗对英格兰老年人新冠病毒相关症状、住院及死亡率的有效性:检测阴性病例对照研究
BMJ. 2021 May 13;373:n1088. doi: 10.1136/bmj.n1088.
6
Changes in COVID-19 in-hospital mortality in hospitalised adults in England over the first seven months of the pandemic: An observational study using administrative data.疫情头七个月英格兰住院成人中新冠病毒肺炎住院死亡率的变化:一项使用行政数据的观察性研究
Lancet Reg Health Eur. 2021 Jun;5:100104. doi: 10.1016/j.lanepe.2021.100104. Epub 2021 Apr 30.
7
Ethnic differences in SARS-CoV-2 infection and COVID-19-related hospitalisation, intensive care unit admission, and death in 17 million adults in England: an observational cohort study using the OpenSAFELY platform.在英格兰 1700 万成年人中,观察性队列研究使用 OpenSAFELY 平台发现 SARS-CoV-2 感染以及与 COVID-19 相关的住院、重症监护病房入院和死亡的种族差异。
Lancet. 2021 May 8;397(10286):1711-1724. doi: 10.1016/S0140-6736(21)00634-6. Epub 2021 Apr 30.
8
Patient factors and temporal trends associated with COVID-19 in-hospital mortality in England: an observational study using administrative data.英格兰 COVID-19 住院患者病死率的相关患者因素和时间趋势:基于行政数据的观察性研究。
Lancet Respir Med. 2021 Apr;9(4):397-406. doi: 10.1016/S2213-2600(20)30579-8. Epub 2021 Feb 15.
9
Prognostic Factors for 30-Day Mortality in Critically Ill Patients With Coronavirus Disease 2019: An Observational Cohort Study.新冠肺炎危重症患者 30 天死亡率的预后因素:一项观察性队列研究。
Crit Care Med. 2021 Jan 1;49(1):102-111. doi: 10.1097/CCM.0000000000004740.
10
Does nosocomial COVID-19 result in increased 30-day mortality? A multi-centre observational study to identify risk factors for worse outcomes in patients with COVID-19.医院获得性 COVID-19 是否会导致 30 天死亡率增加?一项多中心观察性研究,旨在确定 COVID-19 患者预后不良的危险因素。
J Hosp Infect. 2021 Jan;107:91-94. doi: 10.1016/j.jhin.2020.09.017. Epub 2020 Sep 17.